Total Payments
$2,281
2024 Payments
$827.82
Companies
24
Transactions
62
Medicare Patients
2,423
Medicare Billing
$222,155
Payment Breakdown by Category
Food & Beverage$2,281 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,281 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $337.98 | 5 | $0 (2024) |
| Boston Scientific Corporation | $211.75 | 4 | $0 (2024) |
| PFIZER INC. | $187.68 | 5 | $0 (2024) |
| UROGEN PHARMA, INC. | $174.35 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $159.27 | 4 | $0 (2024) |
| KARL STORZ Endoscopy-America | $141.42 | 1 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $136.08 | 7 | $0 (2024) |
| C. R. Bard, Inc. & Subsidiaries | $126.50 | 1 | $0 (2018) |
| PROCEPT BioRobotics Corporation | $112.95 | 2 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $100.88 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $827.82 | 34 | PROCEPT BioRobotics Corporation ($112.95) |
| 2023 | $401.86 | 16 | UroGen Pharma, Inc. ($106.33) |
| 2022 | $64.85 | 3 | Rochester Medical Corporation ($44.12) |
| 2019 | $435.36 | 4 | Astellas Pharma US Inc ($185.61) |
| 2018 | $468.29 | 4 | C. R. Bard, Inc. & Subsidiaries ($126.50) |
| 2017 | $82.53 | 1 | Allergan Inc. ($82.53) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.45 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/18/2024 | Laborie Medical Technologies Corp. | Urgent PC Neuromodulation System (Device) | Food and Beverage | Cash or cash equivalent | $17.57 | General |
| Category: Urology | ||||||
| 10/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/15/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: HORMONE THERAPY | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Boston Scientific Corporation | Tria Firm (Device) | Food and Beverage | In-kind items and services | $48.77 | General |
| Category: Tria_URO | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Oncology | ||||||
| 08/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | CIVCO Medical Instruments | — | Food and Beverage | Cash or cash equivalent | $19.63 | General |
| 08/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Solyx_URO | ||||||
| 07/18/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: UROTHELIAL CANCER | ||||||
| 07/12/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $76.74 | General |
| Category: UROLOGY | ||||||
| 07/08/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 07/03/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: OS | ||||||
| 06/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $32.34 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/04/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: NONE | ||||||
| 05/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: UROLOGY | ||||||
| 05/22/2024 | Laborie Medical Technologies Corp. | — | Food and Beverage | Cash or cash equivalent | $27.52 | General |
| 05/15/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $35.09 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,276 | 1,846 | $349,179 | $149,703 |
| 2022 | 16 | 818 | 2,338 | $199,020 | $60,461 |
| 2021 | 8 | 245 | 259 | $15,561 | $11,276 |
| 2020 | 2 | 84 | 87 | $1,093 | $715.58 |
Total Patients
2,423
Total Services
4,530
Medicare Billing
$222,155
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 292 | 477 | $116,567 | $41,814 | 35.9% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 12 | 53 | $52,376 | $33,040 | 63.1% |
| 52649 | Complete laser fragmentation of prostate including control of bleeding using an endoscope | Facility | 2023 | 30 | 30 | $54,089 | $18,028 | 33.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 131 | 131 | $40,629 | $14,433 | 35.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 65 | 69 | $18,086 | $11,899 | 65.8% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 12 | 12 | $16,760 | $10,689 | 63.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 89 | $15,371 | $5,589 | 36.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 13 | $5,850 | $3,777 | 64.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 26 | 27 | $3,668 | $2,735 | 74.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 19 | $4,997 | $1,877 | 37.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 173 | 226 | $5,680 | $1,588 | 28.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 200 | 302 | $4,669 | $1,174 | 25.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 23 | $1,725 | $1,084 | 62.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 167 | 275 | $4,125 | $934.69 | 22.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,223 | $756.33 | 23.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 15 | $645.00 | $257.70 | 40.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 17 | 72 | $720.00 | $27.85 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 157 | $24,454 | $14,692 | 60.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 114 | 114 | $28,924 | $13,453 | 46.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 55 | 56 | $38,248 | $10,158 | 26.6% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 12 | 16 | $7,650 | $4,827 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 57 | $11,214 | $3,721 | 33.2% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2022 | 11 | 1,401 | $22,226 | $2,920 | 13.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 11 | 11 | $5,433 | $2,593 | 47.7% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 12 | 30 | $27,318 | $1,936 | 7.1% |
About Joseph Ivey
Joseph Ivey is a Urology healthcare provider based in Cleveland, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2017. The National Provider Identifier (NPI) number assigned to this provider is 1376079269.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joseph Ivey has received a total of $2,281 in payments from pharmaceutical and medical device companies, with $827.82 received in 2024. These payments were reported across 62 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,281).
As a Medicare-enrolled provider, Ivey has provided services to 2,423 Medicare beneficiaries, totaling 4,530 services with total Medicare billing of $222,155. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Cleveland, TN
- Active Since 05/11/2017
- Last Updated 12/05/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1376079269
Products in Payments
- MYRBETRIQ (Drug) $303.83
- XTANDI (Drug) $187.68
- JELMYTO (Drug) $174.35
- ERLEADA (Drug) $159.27
- CMOS VIDEO URETEROSCOPE, 8.5 FR. X 675MM (Device) $141.42
- ENDOBEAM (Device) $126.50
- LITHOVUE (Device) $124.80
- AQUABEAM SYSTEM (Device) $112.95
- PROVENGE (Drug) $100.88
- INTERSTIM (Device) $88.06
- GEMTESA (Drug) $84.08
- BOTOX OAB (Drug) $82.53
- Tria Firm (Device) $73.43
- UROLIFT (Device) $63.26
- Nubeqa (Drug) $59.61
- XT CDX (Device) $56.46
- ORGOVYX (Drug) $52.00
- LUPRON DEPOT (Drug) $28.27
- ADSTILADRIN (Biological) $23.86
- AIRSEAL (Device) $21.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Cleveland
Howard Goldman, Md, MD
Urology — Payments: $688,743
Urology $688,743
Jihad Kaouk, Md, MD
Urology — Payments: $258,551
Urology $258,551
Sandip Vasavada, Md, MD
Urology — Payments: $247,878
Urology $247,878
Petar Bajic, M.d, M.D
Urology — Payments: $238,227
Urology $238,227
Dr. Sriharan Sivalingam, Md, MD
Urology — Payments: $210,140
Urology $210,140
Ruben Olivares, Md, MD
Urology — Payments: $174,034
Urology $174,034